Search

Your search keyword '"Roberson, Daniel S."' showing total 27 results
Start Over Author "Roberson, Daniel S."
27 results on '"Roberson, Daniel S."'

3. Reply by Authors

Author

Harmatz, I. Mitchell, Alkhatib, Khalid Y., Leff, Morgan, Nolazco, José I., Michel, Katharine F., Slinger, Michelle, McLauchlan, Nathaniel, Cortese, Brian D., Roberson, Daniel S., Schurhamer, Benjamin, Lee, Daniel J., Malkowicz, S. Bruce, Trinh, Quoc-Dien, Bivalacqua, Trinity J., Guzzo, Thomas J., and Pierorazio, Phillip M.

Published
2024
Full Text
View/download PDF

5. BLADDER PRESERVATION in localized, muscle-invasive bladder cancer: Current state of affairs

Author

Roberson, Daniel S., Xia, Leilei, and Bivalacqua, Trinity J.

Subjects
Care and treatment, Research, Bladder cancer -- Care and treatment, Chemotherapy -- Research, Cancer research, Tumor removal -- Research, Oncology, Experimental, Cancer -- Chemotherapy -- Research
Abstract

INTRODUCTION In 2024, cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) with pelvic lymph node dissection (PLND) remains the gold standard, curative treatment for eligible patients with nonmetastatic muscle-invasive [...]

Published
2024

7. Residual cancer at radical cystectomy with or without neoadjuvant chemotherapy: a pathological stage‐matched comparison.

Author

Xia, Leilei, Knudsen, J. Everett, Roberson, Daniel S., Wood, Erika L., Dadabhoy, Anosh, Romano, Sofia, Guzzo, Thomas J., Bivalacqua, Trinity J., and Daneshmand, Siamak

Subjects
CANCER patients, PATIENT selection, CANCER chemotherapy, CANCER invasiveness, LYMPHADENECTOMY, IMMUNOTHERAPY
Abstract

The article published in BJU International explores the outcomes of patients with residual cancer at radical cystectomy (RC) with or without neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer. The study, based on National Cancer Database (NCDB) data, found that NAC followed by RC was associated with improved overall survival in certain pathological stages, but worse outcomes in others. The research highlights the need for better selection criteria for NAC and the exploration of novel systemic therapies for high-risk patients with locally advanced disease. Limitations include the retrospective nature of the study and the lack of detailed information on chemotherapy regimens. [Extracted from the article]

Published
2025
Full Text
View/download PDF

9. MP68-01 SMOKING, EXERCISE AND PHYSICAL ACTIVITY ARE INDEPENDENTLY ASSOCIATED WITH MENTAL HEALTH IN PROSTATE CANCER PATIENTS AND SURVIVORS: BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM (BRFSS) STUDY

Author

Alkhatib, Khalid Y., primary, Roberson, Daniel S., additional, Briggs, Logan G., additional, Nolazco, Jose I., additional, Bivalacqua, Trinity J., additional, Leff, Morgan, additional, Harmatz, Ian Mitchell, additional, McLaughlan, Nathaniel, additional, Lee, Daniel J., additional, Malkowicz, Stanley Bruce, additional, Matulewicz, Richard S., additional, Guzzo, Thomas, additional, and Pierorazio, Phillip M., additional

Published
2024
Full Text
View/download PDF

10. PD58-07 THE ROLE OF EXERCISE ON PHYSICAL AND MENTAL HEALTH IN KIDNEY CANCER

Author

Alkhatib, Khalid Y., primary, Slinger, Michelle, additional, Roberson, Daniel S., additional, Briggs, Logan G., additional, Cole, Alexander P., additional, Mossanen, Matthew, additional, Harmatz, Ian Mitchell, additional, Leff, Morgan, additional, Cortese, Brian D., additional, McLaughlan, Nathaniel, additional, Bivalacqua, Trinity J., additional, Lee, Daniel J., additional, Trinh, Quoc-Dien, additional, Malkowicz, Stanley Bruce, additional, Guzzo, Thomas, additional, and Pierorazio, Phillip M., additional

Published
2024
Full Text
View/download PDF

12. MP02-07 VIRTUAL CARE AS A TOOL TO IMPROVE HEALTH EQUITY? A NATIONAL RACIAL AND ETHNIC ANALYSIS OF TELEMEDICINE USE AMONG CANCER PATIENTS DURING COVID-19

Author

Cortese, Brian D., primary, Alkhatib, Khalid Y., additional, Harmatz, Ian Mitchell, additional, Leff, Morgan, additional, McLaughlan, Nathaniel, additional, Roberson, Daniel S., additional, Michel, Katharine F., additional, Schurhamer, Benjamin, additional, Lee, Daniel J., additional, Guzzo, Thomas, additional, Pierorazio, Phillip M., additional, and Talwar, Ruchika, additional

Published
2024
Full Text
View/download PDF

13. PD38-12 NATIONAL PERFORMANCE OF LYMPHADENECTOMY FOR MUSCLE-INVASIVE UROTHELIAL CANCER AND AN EXPLORATORY ANALYSIS TO DEFINE OPTIMAL LYMPH NODE YIELD BASED ON SOUTHWEST ONCOLOGY GROUP S1011 TRIAL

Author

Xia, Leilei, primary, Roberson, Daniel S., additional, Wood, Erika L., additional, Dadabhoy, Anosh, additional, Knudsen, Everett, additional, Romano, Sofia, additional, Guzzo, Thomas J., additional, Bivalacqua, Trinity J., additional, and Daneshmand, Siamak, additional

Published
2024
Full Text
View/download PDF

15. MP49-06 PROSTATE SPECIFIC ANTIGEN SCREENING AMONGST SMOKERS: A U.S. NATIONAL BEHAVIORAL ANALYSIS

Author

Harmatz, Ian Mitchell, primary, Alkhatib, Khalid Y., additional, Leff, Morgan, additional, Cortese, Brian D., additional, McLaughlan, Nathaniel, additional, Roberson, Daniel S., additional, Michel, Katharine F., additional, Schurhamer, Benjamin, additional, Lee, Daniel J., additional, Malkowicz, Stanley Bruce, additional, Bivalacqua, Trinity J., additional, Guzzo, Thomas, additional, and Pierorazio, Phillip M., additional

Published
2024
Full Text
View/download PDF

16. VIRTUAL CARE AS A TOOL TO IMPROVE HEALTH EQUITY? A NATIONAL RACIAL AND ETHNIC ANALYSIS OF TELEMEDICINE UTILIZATION AMONG CANCER PATIENTS AND SURVIVORS DURING COVID-19

Author

Cortese, Brian D., primary, Alkatib, Khalid Y., additional, Harmatz, I. Mitchell, additional, Leff, Morgan A., additional, Mclauchlan, Nathaniel, additional, Michel, Katharine F., additional, Roberson, Daniel S., additional, Schurhamer, Benjamin, additional, Lee, Daniel J., additional, Guzzo, Thomas J., additional, Pierorazio, Phillip M., additional, and Talwar, Ruchika, additional

Published
2024
Full Text
View/download PDF

17. PROSTATE SPECIFIC ANTIGEN SCREENING AMONGST SMOKERS: A U.S. NATIONAL BEHAVIORAL ANALYSIS

Author

Harmatz, I. Mitchell, primary, Alkatib, Khalid Y., additional, Leff, Morgan A., additional, Cortese, Brian D., additional, Mclauchlan, Nathaniel, additional, Roberson, Daniel S., additional, Michel, Katharine F., additional, Schurhamer, Benjamin, additional, Lee, Daniel J., additional, Malkowicz, S. Bruce, additional, Bivalacqua, Trinity J., additional, Guzzo, Thomas J., additional, and Pierorazio, Phillip M., additional

Published
2024
Full Text
View/download PDF

18. UNDERSTANDING THE RELATIONSHIP BETWEEN INSURANCE TYPE AND TESTICULAR GERM CELL TUMORS STAGE PRESENTATION USING THE NATIONAL CANCER DATABASE (NCDB)

Author

Leff, Morgan A., primary, Alkatib, Khalid Y., additional, Mclauchlan, Nathaniel, additional, Cortese, Brian D., additional, Harmatz, I. Mitchell, additional, Yeguez, Andrea, additional, Johnson, Majorie, additional, Roberson, Daniel S., additional, Michel, Katharine F., additional, Schurhamer, Benjamin, additional, Lee, Daniel J., additional, Malkowicz, S. Bruce, additional, Bivalacqua, Trinity J., additional, Guzzo, Thomas J., additional, Pierorazio, Phillip M., additional, and Talwar, Ruchika, additional

Published
2024
Full Text
View/download PDF

26. MP22-02 PATHOLOGIC AND SURVIVAL OUTCOMES FOLLOWING RADICAL CYSTECTOMY FOR "PROGRESSIVE" AND "DE NOVO" MUSCLE-INVASIVE BLADDER CANCER: A META-ANALYSIS STRATIFIED BY NEOADJUVANT CHEMOTHERAPY STATUS.

Author

Xia, Leilei, Dadabhoy, Anosh, Wood, Erika L., Mehta, Sejal V., Roberson, Daniel S., Guzzo, Thomas J., Bivalacqua, Trinity J., and Daneshmand, Siamak

Subjects
CANCER invasiveness, BLADDER cancer, SURVIVAL rate, NEOADJUVANT chemotherapy, ILEAL conduit surgery, CYSTECTOMY
Published
2024
Full Text
View/download PDF

27. Prognostic significance of sarcomatoid features in metastatic renal cell carcinoma treated with cytoreductive nephrectomy and targeted therapy.

Author

Cortese BD, Chelluri R, Xia L, Ostrowski DA, Roberson DS, Strother M, Ding JM, Schwartz L, Lee DJ, and Guzzo TJ

Abstract

Introduction: The presence of sarcomatoid features in localized renal cell carcinoma (RCC) is associated with worse outcomes. We sought to use a national database to evaluate the outcomes and prognosis of metastatic RCC (mRCC) with sarcomatoid features treated with cytoreductive nephrectomy (CN) and targeted therapy (TT)., Methods: The National Cancer Database (2010-2013) was used to identify patients with mRCC at diagnosis. Only patients who underwent CN followed by TT were included. Kaplan-Meier curves, log-rank test, and multivariate Cox regression analysis were used to compare overall survival (OS) between mRCC with and without sarcomatoid features. Subgroup analysis in patients with clear cell RCC (ccRCC) was performed., Results: A total of 1,427 patients with mRCC treated with CN followed by TT were included of which 364 (26%) had mRCC with sarcomatoid features. mRCC with sarcomatoid features were more likely to have Fuhrman grade 4 cancer. mRCC with sarcomatoid features had worse OS than mRCC without sarcomatoid features (24.6 vs 12.0 months, P < 0.001). For the clear cell cohort, mRCC with sarcomatoid features had worse OS than mRCC without sarcomatoid features (26.2 vs 14.0 months, P < 0.001). Multivariate Cox regression showed sarcomatoid features was significantly associated with worse OS in the overall cohort (hazard ratio [HR] =1.63, 95% confidence interval [CI] =1.38-1.91, P < 0.001) and the ccRCC subcohort (HR=1.53, 95% CI=1.23-1.90, P < 0.001)., Discussion/conclusion: mRCC with sarcomatoid features treated with CN and TT has a very poor and drastically different prognosis compared with mRCC without sarcomatoid features. With the expansion of systemic RCC therapies, investigation is needed to optimize treatment in this high-risk cohort., Competing Interests: None., (AJCEU Copyright © 2022.)

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results